Patents Assigned to Minu, LLC
  • Patent number: 7341599
    Abstract: An intraocular lens for modifying the refractive abilities of a natural lens or an existing artificial lens in an eye to correct for vision disorders such as presbyopia, myopia, hyperopia or astigmatism. Specifically, the lens system can be configured so that it does not effect far vision, while effecting near vision using a plus lens to correct for presbyopia. The lens system includes a lens portion and fastening members, with the lens portion being movably secured to at least one of the fastening members so that the position of the lens portion can be modified with respect to the optical axis, and the overall length of the lens system can be increased or decreased.
    Type: Grant
    Filed: May 13, 2003
    Date of Patent: March 11, 2008
    Assignee: Minu, LLC
    Inventor: Gholam A. Peyman
  • Publication number: 20070142828
    Abstract: The present invention relates to a system for altering the refractive properties of an eye. The system includes a device configured to be positioned adjacent a portion the cornea of the eye, a cross linker, adapted to be applied to the cornea, a device for emitting ultraviolet rays at the cornea, and a control system configured to monitor the emitting device.
    Type: Application
    Filed: February 20, 2007
    Publication date: June 21, 2007
    Applicant: Minu, LLC
    Inventor: Gholam Peyman
  • Patent number: 7220224
    Abstract: The present invention relates to a method of displacing an area of the macula of an eye, including the steps of placing a substance below the surface of the retina, folding the retina to form a folded portion of the retina, and affixing the folded portion, so that the folded portion substantially maintains a folded shape.
    Type: Grant
    Filed: July 24, 2003
    Date of Patent: May 22, 2007
    Assignee: Minu, LLC
    Inventor: Gholam A. Peyman
  • Patent number: 7147636
    Abstract: A device for reshaping the cornea to correct the refractive error thereof. A first electrode is adapted to be heated and inserted into the corneal stroma of the eye, thereby reshaping a portion of the cornea. A second electrode is adapted to be heated and inserted into the corneal stroma of the eye, thereby reshaping a portion of the cornea. A member couples the first and the second electrodes together, allowing for change of the refractive power of the cornea, while avoiding irregular shrinkage of the corneal tissue.
    Type: Grant
    Filed: September 19, 2002
    Date of Patent: December 12, 2006
    Assignee: Minu, LLC
    Inventor: Gholam A. Peyman
  • Patent number: 6942655
    Abstract: Age-related macular degeneration (AMD) results in the formation of new blood vessels in the eye. The walls of these vessels leak fluid, which causes scarring in the surrounding tissue and results in reduced vision or loss of vision. Photodynamic therapy (PDT) alone has been used to treat AMD, but many retreatments are needed, which cause further damage to the already diseased area. Laser treatment to coagulate the fluid actually causes additional new vessels to form. However, the inventive method of treating patients with both PDT and scatter threshold laser coagulation therapy surprisingly either improved vision, or prevented further loss of vision. Moreover, the combined treatment eliminated the need for retreatment, and did not generate new vessel growth. Threshold laser coagulation and PDT may be administered within the same treatment session or either may be administered first and the other may be administered within ninety days.
    Type: Grant
    Filed: March 27, 2002
    Date of Patent: September 13, 2005
    Assignee: Minu, LLC
    Inventor: Gholam A. Peyman
  • Patent number: 6936043
    Abstract: Age-related macular degeneration (AMD) results in the formation of new blood vessels in the eye. The walls of these vessels leak fluid, which causes scarring in the surrounding tissue, resulting in reduced vision or loss of vision. Photodynamic therapy (PDT) alone has been used to treat AMD, but many retreatments are needed, which cause further damage to the already diseased area. Laser treatment to coagulate the fluid actually causes additional new vessels to form. However, the inventive method of treating patients with both PDT and laser coagulation surprisingly either improved vision, or prevented further loss of vision. Moreover, the combined treatment eliminated the need for retreatment, and did not generate new vessel growth. Laser coagulation and PDT may be administered within the same treatment session or either may be administered first and the other may be administered within ninety days.
    Type: Grant
    Filed: November 13, 2001
    Date of Patent: August 30, 2005
    Assignee: Minu, LLC
    Inventor: Gholam A. Peyman
  • Patent number: 6855163
    Abstract: A system adapted to modify refractivity of a cornea of an eye, including a first component, and adapted to be implanted at a first depth in the cornea. A second component, separate from the first component, is adapted to be implanted at a second depth in the cornea at a position relative to the first component, such that an axis passing through the eye parallel to the optical axis passes through the second component without passing through the first component. The second depth is closer to the front surface of the cornea than is the first depth.
    Type: Grant
    Filed: July 19, 2002
    Date of Patent: February 15, 2005
    Assignee: Minu, LLC
    Inventor: Gholam A. Peyman